m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00069)
| Target Name | hsa_circ_0058493 (Circ_RHBDD1) | ||||
|---|---|---|---|---|---|
| Gene Name | Circ_RHBDD1 | ||||
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
Circ_RHBDD1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
| Response Summary | In hepatocellular carcinoma, hsa_circ_0058493 contained m6A methylation sites and that METTL3 mediated the degree of methylation modification of hsa_circ_0058493. YTHDC1 could bind to hsa_circ_0058493 and promote its intracellular localization from the nucleus to the cytoplasm. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| Pathway Response | Hepatocellular carcinoma | hsa05225 | ||
| Cell Process | Cell growth and metastasis | |||
| In-vitro Model | BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 |
| HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| MHCC97-H | Adult hepatocellular carcinoma | Homo sapiens | CVCL_4972 | |
| SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
| SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
| In-vivo Model | Groups of HCT116-Luc-shCtrl, HCT116-Luc-shLINC00460, and HCT116-Luc-shLINC00460 + HMGA1 cells (5 × 106) were injected subcutaneously into the flanks of mice correspondingly. | |||
YTH domain-containing protein 1 (YTHDC1) [READER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
| Response Summary | In hepatocellular carcinoma, hsa_circ_0058493 contained m6A methylation sites and that METTL3 mediated the degree of methylation modification of hsa_circ_0058493. YTHDC1 could bind to hsa_circ_0058493 and promote its intracellular localization from the nucleus to the cytoplasm. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| Pathway Response | Hepatocellular carcinoma | hsa05225 | ||
| Cell Process | Cell growth and metastasis | |||
| In-vitro Model | BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 |
| HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| MHCC97-H | Adult hepatocellular carcinoma | Homo sapiens | CVCL_4972 | |
| SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
| SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
| In-vivo Model | Groups of HCT116-Luc-shCtrl, HCT116-Luc-shLINC00460, and HCT116-Luc-shLINC00460 + HMGA1 cells (5 × 106) were injected subcutaneously into the flanks of mice correspondingly. | |||
Liver cancer [ICD-11: 2C12]
| In total 2 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
| Response Summary | In hepatocellular carcinoma, hsa_circ_0058493 contained m6A methylation sites and that METTL3 mediated the degree of methylation modification of hsa_circ_0058493. YTHDC1 could bind to hsa_circ_0058493 and promote its intracellular localization from the nucleus to the cytoplasm. | |||
| Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Hepatocellular carcinoma | hsa05225 | ||
| Cell Process | Cell growth and metastasis | |||
| In-vitro Model | BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 |
| HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| MHCC97-H | Adult hepatocellular carcinoma | Homo sapiens | CVCL_4972 | |
| SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
| SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
| In-vivo Model | Groups of HCT116-Luc-shCtrl, HCT116-Luc-shLINC00460, and HCT116-Luc-shLINC00460 + HMGA1 cells (5 × 106) were injected subcutaneously into the flanks of mice correspondingly. | |||
| Experiment 2 Reporting the m6A-centered Disease Response | [2] | |||
| Response Summary | In hepatocellular carcinoma, hsa_circ_0058493 contained m6A methylation sites and that METTL3 mediated the degree of methylation modification of hsa_circ_0058493. YTHDC1 could bind to hsa_circ_0058493 and promote its intracellular localization from the nucleus to the cytoplasm. | |||
| Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
| Target Regulator | YTH domain-containing protein 1 (YTHDC1) | READER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Hepatocellular carcinoma | hsa05225 | ||
| Cell Process | Cell growth and metastasis | |||
| In-vitro Model | BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 |
| HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| MHCC97-H | Adult hepatocellular carcinoma | Homo sapiens | CVCL_4972 | |
| SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 | |
| SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
| In-vivo Model | Groups of HCT116-Luc-shCtrl, HCT116-Luc-shLINC00460, and HCT116-Luc-shLINC00460 + HMGA1 cells (5 × 106) were injected subcutaneously into the flanks of mice correspondingly. | |||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Histone modification
m6A Regulator: YTH domain-containing protein 1 (YTHDC1)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT03486 | ||
| Epigenetic Regulator | Histone acetyltransferase p300 (P300) | |
| Regulated Target | Histone H3 lysine 18 lactylation (H3K18la) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver cancer | |
Non-coding RNA
m6A Regulator: Methyltransferase-like 3 (METTL3)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05547 | ||
| Epigenetic Regulator | hsa_circ_0058493 (Circ_RHBDD1) | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Liver cancer | |
m6A Regulator: YTH domain-containing protein 1 (YTHDC1)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05548 | ||
| Epigenetic Regulator | hsa_circ_0058493 (Circ_RHBDD1) | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Liver cancer | |
References